Analyst consensus rating

Quoin Pharmaceuticals Analyst Rating: Strong Buy

Direct answer

Quoin Pharmaceuticals's consensus rating is Strong Buy.

9 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $19.89.
Forecast evidence checked November 21, 2026.

Get free Quoin Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$3.28
Average price target
$19.89
High price target
$35.00
Low price target
$12.00
Low target gap
+265.9%
Target upside
+506.4%
High target gap
+967.1%
Target range width
701.2%
Consensus rating
Strong Buy
Analysts
9
Evidence date
November 21, 2026
Valid through
November 28, 2026

Read the frequently asked questions.

What is the analyst consensus rating for Quoin Pharmaceuticals?

Quoin Pharmaceuticals has a verified Strong Buy consensus. The same dataset has an average price target of $19.89.

How far are Quoin Pharmaceuticals's low and high targets from the recorded price?

The low target implies +265.9%, while the high target implies +967.1%.

How many analysts are included in Quoin Pharmaceuticals's consensus?

The verified consensus includes 9 analysts.

How is Quoin Pharmaceuticals's target upside or downside calculated?

The average target of $19.89 is divided by the recorded price of $3.28, then one is subtracted to produce +506.4%. This does not guarantee a future return.

When was Quoin Pharmaceuticals's analyst forecast verified?

The data was verified on 2026-11-21. The dataset is valid through 2026-11-28.